Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-09-05
1998-06-02
Rotman, Alan L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546114, A61K 3144, C07D49504
Patent
active
057600538
DESCRIPTION:
BRIEF SUMMARY
CROSS-REFERENCE
This application is a 371 of PCT/JP95/02057 filed Oct. 6, 1995.
BACKGROUND OF THE INVENTION
1. Field of Invention
The present invention relates to .gamma.-diketone compound derivatives having inhibitory activity against platelet aggregation and pharmaceutical compositions useful for the treatment and prevention of thrombotic diseases.
2. Background Art
Cardiovascular diseases are increased along with the change of dietary habits and the increase of advanced ages. Almost fifty percent of these diseases may be caused by thrombus.
Platelets in plasma are mainly associated with the formation of thrombus in organisms. For the purpose of the treatment and prevention of thrombotic diseases in clinical practice, there have been used a medicine which suppresses the functions of platelet or inhibits the aggregation of platelets, for example, aspirin which inhibits cyclooxygenase and ticlopidine which activates adenylcyclase.
In recent years, glycoproteins on platelet membrane have been progressively studied. As a result, it has been elucidated that the membrane glycoprotein called GPIIb/IIIa is a receptor of fibrinogen. This has therefore led to the expectation that a GPIIb/IIIa antagonist would become an inhibitor of platelet aggregation having a novel action mechanism effectively used for the treatment and prevention of the thrombotic diseases (Trends in Pharmacological Science, 13, 413, 1992).
The compounds as the GPIIb/IIIa antagonist include, for examples, monoclonal antibodies (Ann. N.Y. Acad. Sci., 614, 193, 1991), tripeptide derivatives comprising arginine-glycine-aspartic acid (J. Med. Chem., 35, 2040, 1992), amidinophenyl derivatives (J. Med. Chem., 35, 4393, 1992; Japanese Patent Laid-Open Publication Nos. 264068/1992, 334351/1992, EP-A-483667, EP-A-502536, EP-A-525629, EP-A-529858, EP-A-537980, WO-9307867 and WO-9402472), tyrosine derivatives (J. Med. Chem., 35, 4640, 1992), and piperidine derivatives (EP-A-512831, EP-A-540334 and EP-A-578535).
Further, for .gamma.-diketone compounds, compounds having a peptide bond are known in the art (Japanese Patent Laid-Open Publication No. 235853/1990, WO09307867 and the like), whereas no compounds free from a peptide bond are known in the art. It is expected that such compounds not having any peptide bond are less likely to be metabolized by peptidases in vivo. Therefore, they are potentially promissing compounds which can offer prolonged duration of efficacy.
On the other hand, the development of a drug, not having side effects such as hemorrhage and with a highly selective function, as a therapeutic or preventive agent of thrombotic diseases has been desired in the art.
SUMMARY OF THE INVENTION
The present inventors have now found that a certain kind of a compound becomes a GPIIb/IIIa antagonist.
Thus, an object of the present invention is to provide novel compounds having inhibitory activity against the aggregation of platelets.
Another object of the present invention is to provide a pharmaceutical composition comprising a novel compound having the above effect.
Further object of the present invention is to provide a therapeutic or preventive method of thrombotic diseases which comprises administering a novel compound having the above activity.
Further object of the present invention is to provide the use of the novel compound having the above activity for preparing a pharmaceutical composition used for the therapy or prevention of thrombotic disorders. The .gamma.-diketone compound according to the present invention is represented by the formula (I): ##STR3## wherein R.sup.1 and R.sup.2 which may be the same or different is hydrogen; lower alkyl in which at least one hydrogen atom may be substituted by hydroxyl, halogen, amino, carboxyl, lower alkoxy, lower alkylamino, or lower alkoxycarbonyl; phenyl in which at least one hydrogen atom of the phenyl may be substituted by hydroxyl, halogen, amino, carboxyl, lower alkoxy, lower alkylamino, lower alkoxycarbonyl, or halo-lower alkyl; or phenyl-lower alkyl in which at least one hydrogen atom
Katano Kiyoaki
Miura Tomoaki
Ohuchi Shokichi
Shitara Eiki
Meiji Seika Kabushiki Kaisha
Rotman Alan L.
LandOfFree
.gamma.-Diketone compounds with inhibitory activity against plat does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with .gamma.-Diketone compounds with inhibitory activity against plat, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and .gamma.-Diketone compounds with inhibitory activity against plat will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1460165